Beacon Pharmaceuticals Ltd. announced earnings results for the third quarter ended March 31, 2020. For the third quarter, the company announced sales was BDT 1,374.991 million compared to BDT 1,162.371 million a year ago. Operating income was BDT 147.542 million compared to BDT 99.537 million a year ago. Net income was BDT 58.671 million compared to BDT 47.463 million a year ago. Basic earnings per share was BDT 0.25 compared to BDT 0.21 a year ago. For the nine months, sales was BDT 4,203.252 million compared to BDT 3,482.347 million a year ago. Operating income was BDT 322.793 million compared to BDT 269.145 million a year ago. Net income was BDT 128.039 million compared to BDT 130.448 million a year ago. Basic earnings per share was BDT 0.55 compared to BDT 0.56 a year ago.